Elevated liver enzymes such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are traditionally interpreted as markers of liver dysfunction, such as in non-alcoholic fatty liver disease (NAFLD) (12, 13). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.